1-3 of 3
Hakim Djaballah, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Implementation of a Novel High-Throughput Screen of Primary Leukemia Cells to Customize Therapy for Relapsed/Refractory Acute Myeloid Leukemia (AML).

Kristen M O'Dwyer, M.D., David Shum, M.S., Mark Heaney, MD, PhD, Renier J. Brentjens, MD, PhD, Peter Maslak, MD, Joseph G Jurcic, MD, Hakim Djaballah, Ph.D., Mark G. Frattini, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2657.
https://doi.org/10.1182/blood.V114.22.2657.2657
Published: 2009
Journal Articles

Discovery and Validation of a Novel Class of Small Molecule Inhibitors of the CDC7 Kinase: Modulation of Tumor Cell Growth in Vitro and In Vivo .

Mark G. Frattini, MD, PhD, David Shum, M.S., Kristen M O'Dwyer, M.D., Renier J. Brentjens, MD, PhD, Peter Maslak, MD, Mark Heaney, MD, PhD, Joseph G Jurcic, MD, Hakim Djaballah, Ph.D., Thomas J Kelly, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 3771.
https://doi.org/10.1182/blood.V114.22.3771.3771
Published: 2009
Journal Articles

Small Molecule Inhibition of Cdc7, a Key Cell Cycle Regulator and Novel Therapeutic Target, Successfully Inhibits Leukemia Cell Growth in Vitro and in Vivo

Mark G. Frattini, MD, PhD, David Shum, M.S., Kristen M O’Dwyer, M.D., Renier J. Brentjens, MD, PhD, Ray Yeh, Ph.D., Peter Maslak, MD, Mark Lawrence Heaney, MD, PhD, Joseph Jurcic, MD, Hakim Djaballah, Ph.D., Thomas J Kelly, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 2668.
https://doi.org/10.1182/blood.V112.11.2668.2668
Published: 2008